MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 999-1003

  Ji, Dong ^a   Lu, Zhong Tang ^a   Li, Yao Qing ^a   Liang, Zhe Yong ^a   Zhang, Peng Fei ^a   Li, Chao ^a   Zhang, Jun Li ^a   Zheng, Xin ^a   Yao, Ying Min ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Glycolysis; Hepatocellular carcinoma; Immunohistochemistry; MACC1; PFKFB2

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; MACC1 PROTEIN, HUMAN; PFKFB2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR INVASION; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHOSPHOFRUCTOKINASE-2; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84894681290     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.999     Document Type: Article

References (25)

1. Bijur GN, Jope RS (2003). Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem, 87, 1427-35.
2. Blum R, Jacob-Hirsch J, Amariglio N, et al (2005). Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res, 65, 999-1006.
3. Boardman LA (2009). Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome medicine, 1, 36.
4. Bobarykina AY, Minchenko DO, Opentanova IL, et al (2006). Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Acta Biochim Pol, 53, 789-99.
5. Bosca L, Mojena M, Ghysdael J (1986). Expression of the v-src or v-fps oncogene increases fructose 2, 6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. Biochem J, 236, 595-9.
6. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
7. Gao, J, Ding F, Liu Q (2013). Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem, 376, 21-32.
8. Gottlob K FAU Majewski N, Majewski N FAU Kennedy S, Kennedy S FAU Kandel E, et al (2001).-Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev, 15, 1406-18.
9. Kawauchi K, Araki K, Tobiume K, & Tanaka N (2008). p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol, 10, 611-8.
10. Kokoszynska K, Krynski J, Rychlewski L, et al (2009). Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochimica Polonica, 56, 317-323.
11. Minchenko OH, Opentanova IL, Ogura T, et al (2005). Expression and hypoxia-respo-nsiveness of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 inmammary gland malignant cell lines. Acta Biochim Pol, 52, 881-8.
12. Moon JS, Jin W J, Kwak, JH, et al (2011). Androgen stimulates glyco-lysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 in prostate cancer cells. Biochem J, 433, 225-33.
13. Novellasdemunt L, Tato I, Navarro-Sabate A, et al (2013). Akt-dependent activation of heart 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase (PFKFB2) isoenzyme by amino acids. J Biol Chem, 288, 10640-51.
14. Neary CL FAU Pastorino JG, & Pastorino JG (2013).-Akt inhibition promotes hexokinase 2 redistribution and glucose uptake in cancer cells. J Cell Physiol, 228, 1943-8.
15. Okar DA, Manzano A, Navarro-Sabate A, et al (2001). PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate. Trends Biochem Sci, 26, 30-35.
16. Pelicano H, Martin DS, Xu RH, & Huang P (2006). Glycolysis inhibition for anticancer treatment. Oncogene, 25, 4633-46.
17. Rider MH, Bertrand L, Vertommen D, et al (2004). 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J, 381, 561-79.
18. Roberts DJ, Tan-Sah VP, Tan-Sah VP, et al (2013). Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem, 288, 32638.
19. Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B (2008). Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs, 17, 1533-45.
20. Stein U, Smith J, Walther W, Arlt F (2009). MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle, 8, 2467-9.
21. Stein U, Walther W, Arlt F, et al (2009). MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med, 15, 59-67.
22. Van Schaftingen E (1987). Fructose 2, 6-bisphosphate. Adv Enzymol Relat Areas Mol Biol, 59, 315-95.
23. WARBURG O (1956). On the origin of cancer cells. Science, 123, 309-314.
24. Yalcin A, Clem BF, Simmons A, et al (2009). Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem, 284, 24223-32.
25. Zeller KI, Zhao X, Lee CW, et al (2006). Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci USA, 103, 17834-9.